Before the discovery of Ano1 as a CaCC, Ano1 has been found to be overexpressed in many cancers including gastrointestinal stromal tumor, esophageal squamous cell cancer, and head and neck squamous cell carcinoma (HNSCC) [13-16]. This evidence concerns the gene ANO1 and cancer.